Search Results 241-250 of 15451 for Linaclotide
View patient resources recommended by the Immuno-Epigenetics Lab led by William A. Faubion Jr., M.D., at Mayo Clinic's campus in Minnesota.
This will be assessed in patients with chronic spontaneous urticaria (CSU) who have completed a preceding ligelizumab study and have relapsed, following ...
In this study, participants with MSI-H or dMMR advanced colorectal carcinoma will be randomly assigned to receive either pembrolizumab or the Investigator's ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Inclusion Criteria: Patients with Barrett's Esophagus (BE) or Esophageal Adenocarcinoma (EAC) that are planned for Endoscopic Submucosal Dissection (ESD) ...
About this study. The purpose of this study is to understand how bacteria in the intestines interact with the inflammation process in patients with ...
The purpose of this study is to explore the acceptability of tethered capsule endomicroscopy (TCE) for Barrett's Esophagus (BE) surveillance following CRIM. BE ...
This randomized phase I trial studies the side effects and best dose of linaclotide acetate in preventing colorectal cancer in healthy volunteers.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.